Volcano Corp (NASDAQ:VOLC)

CAPS Rating: 2 out of 5

The Company is engages in the development, manufacture and commercialization of intravascular ultrasound and functional measurement products that are used for the diagnosis and treatment of vascular and structural heart disease.

Recs

0
Player Avatar DonewithCorpAmer (< 20) Submitted: 2/16/2008 4:37:20 PM : Outperform Start Price: $13.49 VOLC Score: +111.96

35% yoy rev increase!

Featured Broker Partners


Advertisement